{
  "study": {
    "study_id": "Ojulong2009-Uganda-Mulago-2007-01",
    "title": "Relative prevalence of methicilline resistant Staphylococcus aureus and its susceptibility pattern in Mulago Hospital, Kampala, Uganda",
    "authors": [
      "J. Ojulong",
      "T.P. Mwambu",
      "M. Joloba",
      "F. Bwanga",
      "D.H. Kaddu-Mulindwa"
    ],
    "journal": "Tanzania Journal of Health Research",
    "year_publication": 2009,
    "country_list": [
      "Uganda"
    ],
    "country_iso3": "UGA",
    "region_classification": "ECSA",
    "surgical_specialty": [
      "general",
      "obstetrics/gynecology"
    ],
    "language": "English",
    "data_source_type": "published_full_text",
    "ownership_type": "public",
    "bed_capacity": 1500
  },
  "design": {
    "study_design": "cross_sectional",
    "randomized": false,
    "prospective": false,
    "single_center": true,
    "multi_center": false,
    "inclusion_criteria_text": "Patients with surgical site infections in Surgical, Obstetrics and Gynaecology wards between February and May 2007.",
    "sample_frame": "patients",
    "unit_of_analysis": "isolate",
    "duplicate_publication_likelihood": false
  },
  "setting": {
    "facility_level": "tertiary",
    "urban_rural": "urban",
    "care_setting": "hospital",
    "country_specific_sites": [
      "Mulago National Hospital, Kampala"
    ]
  },
  "eligibility": {
    "population": "Patients with surgical site infections in Surgical, Obstetrics and Gynaecology wards.",
    "classification": "mixed",
    "intervention": "None (observational study of resistance patterns; no intervention applied)",
    "comparator": "None",
    "outcomes_reported": [
      "amr_prevalence"
    ],
    "timeframe_years": "February to May 2007",
    "setting_types": [
      "hospital",
      "surgical_unit",
      "ward"
    ],
    "included_designs": [
      "cross_sectional"
    ],
    "excluded_designs": []
  },
  "timeframe": {
    "data_collection_start_year": 2007,
    "data_collection_start_month": 2,
    "data_collection_end_year": 2007,
    "data_collection_end_month": 5
  },
  "populations": [
    {
      "arm_id": "overall",
      "description": "All patients with surgical site infections from Surgical, Obstetrics and Gynaecology wards at Mulago Hospital during study period.",
      "n_participants": 188,
      "age_group": "mixed",
      "elective_emergency": "unspecified",
      "wound_class": "unspecified",
      "surgical_specialties": [
        "general",
        "obstetrics/gynecology"
      ],
      "provenance": {
        "page": 2,
        "section_heading": "Materials and Methods",
        "text_snippet": "188 pus swabs were collected from patients with surgical site infections."
      }
    }
  ],
  "definitions": {
    "ssi_definition_standard": "unspecified",
    "amr_definition_standard": "CLSI",
    "breakpoint_version": "CLSI 2003",
    "resistance_definition_text": "Oxacillin resistance confirmed by agar screen method and PCR. Susceptibility testing by disc diffusion on Mueller-Hinton agar, interpreted by National Committee for Clinical Laboratory Standards (2003).",
    "outcome_definitions_text": "MRSA defined by oxacillin resistance and PCR confirmation. Antibiotic resistance defined by disc diffusion results.",
    "specimen_type": [
      "wound_swab"
    ]
  },
  "lab_methods": {
    "specimen_collection_method": "Pus swabs collected from surgical site infections.",
    "culture_method": "Culture on Mueller-Hinton agar (Difco, USA) with 24-h incubation at 35°C.",
    "AST_method": [
      "disk_diffusion",
      "agar_screen"
    ],
    "QC_measures": "ATCC 25923 used as control strain for identification and susceptibility tests.",
    "organism_identification_method": "Standard methods; PCR confirmation for MRSA."
  },
  "outcomes": {
    "ssi_incidence": [],
    "amr_proportions": [
      {
        "arm_id": "overall",
        "pathogen": "Staphylococcus aureus",
        "antibiotic": "ciprofloxacin",
        "who_class": "critically_important",
        "n_tested": 17,
        "n_resistant": 12,
        "n_susceptible": 5,
        "ast_method": "disk_diffusion",
        "breakpoint_standard": "CLSI",
        "breakpoint_version": "CLSI 2003",
        "specimen_type": "wound_swab",
        "site": "surgical site/wound",
        "data_period": {
          "start_year": 2007,
          "end_year": 2007
        },
        "mrsa_detection_method": "PCR",
        "zone_diameter_unit": "mm",
        "provenance": {
          "page": 3,
          "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
          "table_id": "Table1",
          "text_snippet": "Ciproﬂ oxacin Resistant 12 70.59 Sensitive 5 29.41"
        }
      },
      {
        "arm_id": "overall",
        "pathogen": "Staphylococcus aureus",
        "antibiotic": "vancomycin",
        "who_class": "critically_important",
        "n_tested": 17,
        "n_resistant": 0,
        "n_susceptible": 17,
        "ast_method": "disk_diffusion",
        "breakpoint_standard": "CLSI",
        "breakpoint_version": "CLSI 2003",
        "specimen_type": "wound_swab",
        "site": "surgical site/wound",
        "data_period": {
          "start_year": 2007,
          "end_year": 2007
        },
        "mrsa_detection_method": "PCR",
        "zone_diameter_unit": "mm",
        "provenance": {
          "page": 3,
          "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
          "table_id": "Table1",
          "text_snippet": "Vancomycin Resistant 0 0 Sensitive 17 100"
        }
      },
      {
        "arm_id": "overall",
        "pathogen": "Staphylococcus aureus",
        "antibiotic": "clindamycin",
        "who_class": "critically_important",
        "n_tested": 17,
        "n_resistant": 0,
        "n_susceptible": 17,
        "ast_method": "disk_diffusion",
        "breakpoint_standard": "CLSI",
        "breakpoint_version": "CLSI 2003",
        "specimen_type": "wound_swab",
        "site": "surgical site/wound",
        "data_period": {
          "start_year": 2007,
          "end_year": 2007
        },
        "mdr_definition_text": "Inducible clindamycin resistance detected by D-test; 82.4% positive.",
        "mrsa_detection_method": "PCR",
        "resistance_gene_markers": "erm gene (inducible resistance)",
        "zone_diameter_unit": "mm",
        "notes": "D-test positive in 82.4% of isolates.",
        "provenance": {
          "page": 3,
          "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
          "table_id": "Table1",
          "text_snippet": "Clindamycin Resistant 0 0 Sensitive 17 100"
        }
      },
      {
        "arm_id": "overall",
        "pathogen": "Staphylococcus aureus",
        "antibiotic": "gentamicin",
        "who_class": "critically_important",
        "n_tested": 17,
        "n_resistant": 10,
        "n_susceptible": 7,
        "ast_method": "disk_diffusion",
        "breakpoint_standard": "CLSI",
        "breakpoint_version": "CLSI 2003",
        "specimen_type": "wound_swab",
        "site": "surgical site/wound",
        "data_period": {
          "start_year": 2007,
          "end_year": 2007
        },
        "mrsa_detection_method": "PCR",
        "zone_diameter_unit": "mm",
        "provenance": {
          "page": 3,
          "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
          "table_id": "Table1",
          "text_snippet": "Gentamycin Resistant 10 58.82 Sensitive 7 41.18"
        }
      },
      {
        "arm_id": "overall",
        "pathogen": "Staphylococcus aureus",
        "antibiotic": "co-trimoxazole",
        "who_class": "highly_important",
        "n_tested": 17,
        "n_resistant": 15,
        "n_susceptible": 2,
        "ast_method": "disk_diffusion",
        "breakpoint_standard": "CLSI",
        "breakpoint_version": "CLSI 2003",
        "specimen_type": "wound_swab",
        "site": "surgical site/wound",
        "data_period": {
          "start_year": 2007,
          "end_year": 2007
        },
        "mrsa_detection_method": "PCR",
        "zone_diameter_unit": "mm",
        "provenance": {
          "page": 3,
          "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
          "table_id": "Table1",
          "text_snippet": "Sulfamethoxazole- Trimethroprim Resistant 15 88.24 Sensitive 2 11.76"
        }
      },
      {
        "arm_id": "overall",
        "pathogen": "Staphylococcus aureus",
        "antibiotic": "chloramphenicol",
        "who_class": "highly_important",
        "n_tested": 17,
        "n_resistant": 15,
        "n_susceptible": 2,
        "ast_method": "disk_diffusion",
        "breakpoint_standard": "CLSI",
        "breakpoint_version": "CLSI 2003",
        "specimen_type": "wound_swab",
        "site": "surgical site/wound",
        "data_period": {
          "start_year": 2007,
          "end_year": 2007
        },
        "mrsa_detection_method": "PCR",
        "zone_diameter_unit": "mm",
        "provenance": {
          "page": 3,
          "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
          "table_id": "Table1",
          "text_snippet": "Chloramphenicol Resistant 15 88.24 Sensitive 2 11.76"
        }
      },
      {
        "arm_id": "overall",
        "pathogen": "Staphylococcus aureus",
        "antibiotic": "erythromycin",
        "who_class": "critically_important",
        "n_tested": 17,
        "n_resistant": 15,
        "n_susceptible": 2,
        "ast_method": "disk_diffusion",
        "breakpoint_standard": "CLSI",
        "breakpoint_version": "CLSI 2003",
        "specimen_type": "wound_swab",
        "site": "surgical site/wound",
        "data_period": {
          "start_year": 2007,
          "end_year": 2007
        },
        "mrsa_detection_method": "PCR",
        "zone_diameter_unit": "mm",
        "provenance": {
          "page": 3,
          "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
          "table_id": "Table1",
          "text_snippet": "Erythromycin Resistant 15 88.24 Sensitive 2 11.76"
        }
      }
    ],
    "morbidity": [],
    "mortality": [],
    "reoperations": [],
    "readmissions": [],
    "length_of_stay": [],
    "costs": [],
    "risk_factors_effects": []
  },
  "interventions": [],
  "stewardship_guidelines": [],
  "policy_capacity": [],
  "qualitative_thematic": {
    "codes": [
      {
        "theme": "amr_prevalence",
        "subtheme": "resistance patterns and rates by pathogen/antibiotic",
        "summary": "High rates of multidrug resistance were observed among MRSA isolates from surgical site infections, with resistance to most commonly available antibiotics except vancomycin and clindamycin (though inducible resistance was common).",
        "evidence_quotes": [
          {
            "quote": "Resistance rates of MRSA were 88.2% for trimethoprim-sulfamethoxazole, 88.2% for erythromycin, 58.8% for gentamycin, 70.6% for ciprofloxacin, and 88.2% for chloramphenicol. All isolates were found to be sensitive to vancomycin and clindamycin though the D-test was found to be positive in 82.4% of the isolates.",
            "page": 1,
            "section": "Abstract"
          }
        ],
        "location_context": "Mulago Hospital, Kampala, Uganda",
        "confidence": "high",
        "provenance": {
          "page": 1,
          "section_heading": "Abstract",
          "text_snippet": "Resistance rates of MRSA were 88.2% for trimethoprim-sulfamethoxazole, 88.2% for erythromycin, 58.8% for gentamycin, 70.6% for ciprofloxacin, and 88.2% for chloramphenicol."
        }
      },
      {
        "theme": "drivers_amr",
        "subtheme": "inappropriate use, IPC gaps, diagnostics delays, policy failures, supply chain, workforce, patient factors",
        "summary": "The high prevalence of multidrug resistant MRSA is attributed to the use of broad-spectrum antibiotics and possible clonal expansion and drug pressure in the community.",
        "evidence_quotes": [
          {
            "quote": "Gentamycin, which was proposed to be an alternative therapy to MRSA infection, was found to be still better in this part of the world (52.6%). This is perhaps due to the different clonal expansion and drug pressure in the community.",
            "page": 3,
            "section": "Discussion"
          },
          {
            "quote": "The use of broad-spectrum antibiotics for treating infections also increases the rate of MRSA and other resistant bacteria.",
            "page": 4,
            "section": "Discussion"
          }
        ],
        "location_context": "Mulago Hospital, Kampala, Uganda",
        "confidence": "moderate",
        "provenance": {
          "page": 3,
          "section_heading": "Discussion",
          "text_snippet": "Gentamycin, which was proposed to be an alternative therapy to MRSA infection, was found to be still better in this part of the world (52.6%)."
        }
      },
      {
        "theme": "microbiology_diagnostics",
        "subtheme": "lab capacity, methods, turnaround times",
        "summary": "MRSA identification was confirmed by standard methods and PCR, with susceptibility testing performed by disc diffusion and agar screen methods according to CLSI standards.",
        "evidence_quotes": [
          {
            "quote": "S. aurues isolates were identified using standard procedures and tested for oxacillin resistance according to methods of the National Committee for Clinical Laboratory Standards.",
            "page": 1,
            "section": "Abstract"
          },
          {
            "quote": "Identification of S. aureus was confirmed by standard methods and susceptibility testing was performed by disc diffusion on Mueller-Hinton agar (Difco, USA) with 24-h incubation at 35°C. Interpretation criteria were those of the National Committee for Clinical Laboratory Standards (2003). Resistance to oxacillin was confirmed by agar screen method using an agar plate containing 6 µg/ml of oxacillin and Mueller-Hinton agar supplemented with NaCl (4% w/v; 0.68 mol/L).",
            "page": 2,
            "section": "Laboratory protocol"
          }
        ],
        "location_context": "Mulago Hospital, Kampala, Uganda",
        "confidence": "high",
        "provenance": {
          "page": 2,
          "section_heading": "Laboratory protocol",
          "text_snippet": "Identification of S. aureus was confirmed by standard methods and susceptibility testing was performed by disc diffusion on Mueller-Hinton agar (Difco, USA) with 24-h incubation at 35°C."
        }
      },
      {
        "theme": "prevention_control",
        "subtheme": "IPC programs, bundles, surveillance practices",
        "summary": "Hand hygiene and avoidance of transmission by caregivers are recognized as effective methods for controlling MRSA spread.",
        "evidence_quotes": [
          {
            "quote": "The first and the most effective way among these are to avoid transmission through hand contamination by the person responsible for caring the infected patients.",
            "page": 4,
            "section": "Discussion"
          }
        ],
        "location_context": "Mulago Hospital, Kampala, Uganda",
        "confidence": "moderate",
        "provenance": {
          "page": 4,
          "section_heading": "Discussion",
          "text_snippet": "The first and the most effective way among these are to avoid transmission through hand contamination by the person responsible for caring the infected patients."
        }
      },
      {
        "theme": "evidence_gaps",
        "subtheme": "explicit gaps and research priorities",
        "summary": "A larger study is recommended to determine antibiotic susceptibility of MRSA in various hospitals in the East African region.",
        "evidence_quotes": [
          {
            "quote": "A further large study with a large sample should be carried out to find antibiotic susceptibility of MRSA in various hospitals in the East African region.",
            "page": 4,
            "section": "Discussion"
          }
        ],
        "location_context": "East African region",
        "confidence": "high",
        "provenance": {
          "page": 4,
          "section_heading": "Discussion",
          "text_snippet": "A further large study with a large sample should be carried out to find antibiotic susceptibility of MRSA in various hospitals in the East African region."
        }
      }
    ]
  },
  "risk_of_bias": {
    "tool_used": "not_reported",
    "domain_judgements": {},
    "overall_judgement": "not_reported",
    "provenance": {}
  },
  "funding_conflicts": {
    "funding_sources": [],
    "provenance": {}
  },
  "notes_flags": [
    {
      "type": [
        "missing_data"
      ],
      "detail": "No SSI incidence data (events/denominator) reported.",
      "provenance": {
        "page": 1,
        "section_heading": "Abstract",
        "text_snippet": "188 pus swabs were collected from patients with surgical site infections."
      }
    },
    {
      "type": [
        "missing_data"
      ],
      "detail": "No clinical outcome data (morbidity, mortality, reoperation, readmission, LOS, costs) reported.",
      "provenance": {
        "page": 1,
        "section_heading": "Abstract",
        "text_snippet": "The objective of this study was to determine the relative prevalence of MRSA among S. aureus isolates from surgical site infections and their antibiotic susceptibility pattern."
      }
    },
    {
      "type": [
        "unit_unclear"
      ],
      "detail": "SSI definition and ascertainment window not specified.",
      "provenance": {
        "page": 2,
        "section_heading": "Materials and Methods",
        "text_snippet": "188 pus swabs were collected from patients with surgical site infections."
      }
    }
  ],
  "provenance_index": [
    {
      "page": 1,
      "section_heading": "Abstract",
      "text_snippet": "Resistance rates of MRSA were 88.2% for trimethoprim-sulfamethoxazole, 88.2% for erythromycin, 58.8% for gentamycin, 70.6% for ciprofloxacin, and 88.2% for chloramphenicol."
    },
    {
      "page": 2,
      "section_heading": "Materials and Methods",
      "text_snippet": "188 pus swabs were collected from patients with surgical site infections."
    },
    {
      "page": 3,
      "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
      "table_id": "Table1",
      "text_snippet": "Ciproﬂ oxacin Resistant 12 70.59 Sensitive 5 29.41"
    },
    {
      "page": 3,
      "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
      "table_id": "Table1",
      "text_snippet": "Vancomycin Resistant 0 0 Sensitive 17 100"
    },
    {
      "page": 3,
      "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
      "table_id": "Table1",
      "text_snippet": "Clindamycin Resistant 0 0 Sensitive 17 100"
    },
    {
      "page": 3,
      "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
      "table_id": "Table1",
      "text_snippet": "Gentamycin Resistant 10 58.82 Sensitive 7 41.18"
    },
    {
      "page": 3,
      "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
      "table_id": "Table1",
      "text_snippet": "Sulfamethoxazole- Trimethroprim Resistant 15 88.24 Sensitive 2 11.76"
    },
    {
      "page": 3,
      "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
      "table_id": "Table1",
      "text_snippet": "Chloramphenicol Resistant 15 88.24 Sensitive 2 11.76"
    },
    {
      "page": 3,
      "section_heading": "Table1: Susceptibility pattern of methicilline resistant Staphylococcus areus isolates",
      "table_id": "Table1",
      "text_snippet": "Erythromycin Resistant 15 88.24 Sensitive 2 11.76"
    },
    {
      "page": 3,
      "section_heading": "Discussion",
      "text_snippet": "Gentamycin, which was proposed to be an alternative therapy to MRSA infection, was found to be still better in this part of the world (52.6%)."
    },
    {
      "page": 4,
      "section_heading": "Discussion",
      "text_snippet": "The first and the most effective way among these are to avoid transmission through hand contamination by the person responsible for caring the infected patients."
    },
    {
      "page": 4,
      "section_heading": "Discussion",
      "text_snippet": "A further large study with a large sample should be carried out to find antibiotic susceptibility of MRSA in various hospitals in the East African region."
    }
  ],
  "extraction_summary": {
    "completeness_score": 70,
    "missing_fields": [
      "ssi_incidence",
      "morbidity",
      "mortality",
      "reoperations",
      "readmissions",
      "length_of_stay",
      "costs",
      "risk_factors_effects",
      "interventions",
      "stewardship_guidelines",
      "policy_capacity",
      "qualitative_thematic.method",
      "qualitative_thematic.participants_n",
      "qualitative_thematic.analysis_approach",
      "qualitative_thematic.casp_appraisal",
      "funding_conflicts.funding_sources",
      "funding_conflicts.conflicts_of_interest",
      "funding_conflicts.role_of_funder",
      "risk_of_bias.tool_used",
      "risk_of_bias.domain_judgements",
      "risk_of_bias.overall_judgement",
      "risk_of_bias.who_made_judgement"
    ],
    "parser_warnings": [
      "No SSI incidence or clinical outcome data reported.",
      "No funding or conflict of interest information found.",
      "No risk of bias assessment reported.",
      "SSI definition and ascertainment window not specified."
    ],
    "confidence_overall": "moderate"
  }
}